Citations (4)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Erika Vacchelli, Norma Bloy, Fernando Aranda, Aitziber Buqué, Isabelle Cremer, Sandra Demaria, Alexander Eggermont, Silvia Chiara Formenti, Wolf Hervé Fridman, Jitka Fucikova, Jérôme Galon, Radek Spisek, Eric Tartour, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2016) Trial Watch: Immunotherapy plus radiation therapy for oncological indications. OncoImmunology 5:9.
Read now
Read now
Articles from other publishers (3)
Yu-Chen Chuang, Jen-Chih Tseng, Li-Rung Huang, Chun-Ming Huang, Chi-Ying F. Huang & Tsung-Hsien Chuang. (2020) Adjuvant Effect of Toll-Like Receptor 9 Activation on Cancer Immunotherapy Using Checkpoint Blockade. Frontiers in Immunology 11.
Crossref
Crossref
Yue-Ting K. Lau, Malini Ramaiyer, Daniel E. Johnson & Jennifer R. Grandis. (2019) Targeting STAT3 in Cancer with Nucleotide Therapeutics. Cancers 11:11, pages 1681.
Crossref
Crossref
Xingli Zhao, Zhuoran Zhang, Dayson Moreira, Yu-Lin Su, Haejung Won, Tomasz Adamus, Zhenyuan Dong, Yong Liang, Hongwei H. Yin, Piotr Swiderski, Raju K. Pillai, Larry Kwak, Stephen Forman & Marcin Kortylewski. (2018) B Cell Lymphoma Immunotherapy Using TLR9-Targeted Oligonucleotide STAT3 Inhibitors. Molecular Therapy 26:3, pages 695-707.
Crossref
Crossref